Remote Ischemic Conditioning of the Human Brain in Dementia Patients (RICBDE)
Primary Purpose
Mild Cognitive Impairment, Dementia, Intermittent Claudication
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Leg ischemia
Sponsored by
About this trial
This is an interventional treatment trial for Mild Cognitive Impairment
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of mild cognitive impairment
- Clinical diagnosis of mild dementia
- Clinical diagnosis of moderate dementia
- Peripheral arteriopathy
Exclusion Criteria:
- Clinical diagnosis of severe dementia
- Not being able to follow the exercise program for more than two days for any reason
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Experimental
No Intervention
Arm Label
Group 90 individuals, baseline assessment before intervention
Remote ischemic condition of the brain
Late cognitive assessment
Arm Description
Baseline Cognitive status assessment
Intermittent claudication induction on a daily basis for 1 month
Late cognitive status assessment 6 months later
Outcomes
Primary Outcome Measures
Measurements to Assess General Cognitive Function
Change in Mini Mental State Examination (minimum value 10 - maximum value 30, higher scores mean a better outcome)
Neuropsychological Assessment
Change Test (higher scores mean a better outcome)
Changes in Functional Cognitive State
Global Deterioration Scale (values 1-7, higher scores mean a worse outcome)
Secondary Outcome Measures
NeuroImaging
Magnetic Resonance Imaging (MRI) (white matter hyperintensities volume)
Neurophysiology
Changes in Event-Related Potential (ERP) (oddball paradigm, auditory ERPs)
Electroencephalography recording
Changes in Electroencephalography (EEG), resting state
Full Information
NCT ID
NCT04168021
First Posted
November 10, 2019
Last Updated
November 18, 2019
Sponsor
Aristotle University Of Thessaloniki
Collaborators
Greek Alzheimer's Association and Related Disorders
1. Study Identification
Unique Protocol Identification Number
NCT04168021
Brief Title
Remote Ischemic Conditioning of the Human Brain in Dementia Patients
Acronym
RICBDE
Official Title
Remote Ischemic Conditioning of the Human Brain in Dementia Patients (RICBDE): Protocol for a Crossover Non-pharmaceutical Intervention Study
Study Type
Interventional
2. Study Status
Record Verification Date
November 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2020 (Anticipated)
Primary Completion Date
August 31, 2021 (Anticipated)
Study Completion Date
December 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aristotle University Of Thessaloniki
Collaborators
Greek Alzheimer's Association and Related Disorders
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study investigates the incidence of remote ischemic conditioning in mild cognitive impairment and dementia patients
Detailed Description
The investigators will study the potential neuroprotection of ischemia/reperfusion (I/R) of a peripheral organ or tissue against cerebral I/R injury in people with mild cognitive impairment as well as early and middle stage dementia.
This crossover study will be held with individuals suffering from peripheral arteriopathy that can cause intermittent claudication after structured exercise, thus inducing extensive transient leg's ischemia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild Cognitive Impairment, Dementia, Intermittent Claudication
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Care ProviderOutcomes Assessor
Allocation
Non-Randomized
Enrollment
90 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group 90 individuals, baseline assessment before intervention
Arm Type
No Intervention
Arm Description
Baseline Cognitive status assessment
Arm Title
Remote ischemic condition of the brain
Arm Type
Experimental
Arm Description
Intermittent claudication induction on a daily basis for 1 month
Arm Title
Late cognitive assessment
Arm Type
No Intervention
Arm Description
Late cognitive status assessment 6 months later
Intervention Type
Behavioral
Intervention Name(s)
Leg ischemia
Intervention Description
potential neuroprotection of ischemia/reperfusion of a peripheral organ or tissue against cerebral I/R injury
Primary Outcome Measure Information:
Title
Measurements to Assess General Cognitive Function
Description
Change in Mini Mental State Examination (minimum value 10 - maximum value 30, higher scores mean a better outcome)
Time Frame
Baseline, 1 and 6 months
Title
Neuropsychological Assessment
Description
Change Test (higher scores mean a better outcome)
Time Frame
Baseline, 1 and 6 months
Title
Changes in Functional Cognitive State
Description
Global Deterioration Scale (values 1-7, higher scores mean a worse outcome)
Time Frame
Baseline, 1 and 6 months
Secondary Outcome Measure Information:
Title
NeuroImaging
Description
Magnetic Resonance Imaging (MRI) (white matter hyperintensities volume)
Time Frame
baseline, 1 month, 6 months
Title
Neurophysiology
Description
Changes in Event-Related Potential (ERP) (oddball paradigm, auditory ERPs)
Time Frame
Baseline, 1 month, 12 months
Title
Electroencephalography recording
Description
Changes in Electroencephalography (EEG), resting state
Time Frame
Baseline, 1 month, 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of mild cognitive impairment
Clinical diagnosis of mild dementia
Clinical diagnosis of moderate dementia
Peripheral arteriopathy
Exclusion Criteria:
Clinical diagnosis of severe dementia
Not being able to follow the exercise program for more than two days for any reason
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data will be available. Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices) will be shared. Study Protocol and Informed Consent Form will also be available. Data will be available (start and end dates) immediately following publication, No end date, with Investigations whose proposed use of the data has been approved by an independent review committee identified for this purpose, and for any purpose types of analysis.
IPD Sharing Time Frame
Data will be available (start and end dates) immediately following publication, No end date
IPD Sharing Access Criteria
To gain access, data requestors will need to sign a data access agreement.
Learn more about this trial
Remote Ischemic Conditioning of the Human Brain in Dementia Patients
We'll reach out to this number within 24 hrs